ResearcherCentre National de la Recherche ScientifiqueActive in the last 2 years
Julie Dardare
Matched on ORCID iD 0000-0002-5315-1852; OpenAlex author ID A5024232075. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 4
2020: 1 paper · 2021: 1 paper · 2022: 1 paper · 2023: 1 paper · 2024: 1 paper · 2025: none · 2026: 2 papers
Papers 7
- Improving Radiation Therapy in Pancreatic Cancer Through Radiosensitization Strategies. Co-author DOI 10.1016/j.ijrobp.2025.09.013↗
- Radiotherapy in the management of PDAC, from past to present. Co-author DOI 10.1016/j.tranon.2025.102632↗
- DDB2 expression lights the way for precision radiotherapy response in PDAC cells, with or without olaparib. Co-author DOI 10.1038/s41420-024-02188-9↗
- CRISPR/Cas9-mediated knock-in of BRCA1/2 mutations restores response to olaparib in pancreatic cancer cell lines. First author DOI 10.1038/s41598-023-45964-w↗
- DDB2 represses epithelial-to-mesenchymal transition and sensitizes pancreatic ductal adenocarcinoma cells to chemotherapy. Co-author DOI 10.3389/fonc.2022.1052163↗
- Epithelial to Mesenchymal Transition in Patients with Pancreatic Ductal Adenocarcinoma: State-of-the-Art and Therapeutic Opportunities. Co-author DOI 10.3390/ph14080740↗
- SMAD4 and the TGFβ Pathway in Patients with Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/ijms21103534↗
Closest collaborators
The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Pauline Gilson · 7 shared papers, 2020–2026 · strength 1.41
- Paper Improving Radiation Therapy in Pancreatic Cancer Through Radiosensitization Strategies. DOI 10.1016/j.ijrobp.2025.09.013↗
- Paper Radiotherapy in the management of PDAC, from past to present. DOI 10.1016/j.tranon.2025.102632↗
- Paper DDB2 expression lights the way for precision radiotherapy response in PDAC cells, with or without olaparib. DOI 10.1038/s41420-024-02188-9↗
- Andréa Witz · 7 shared papers, 2020–2026 · strength 1.41
- Paper Improving Radiation Therapy in Pancreatic Cancer Through Radiosensitization Strategies. DOI 10.1016/j.ijrobp.2025.09.013↗
- Paper Radiotherapy in the management of PDAC, from past to present. DOI 10.1016/j.tranon.2025.102632↗
- Paper DDB2 expression lights the way for precision radiotherapy response in PDAC cells, with or without olaparib. DOI 10.1038/s41420-024-02188-9↗
- Alexandre Harlé · 7 shared papers, 2020–2026 · strength 1.41
- Paper Improving Radiation Therapy in Pancreatic Cancer Through Radiosensitization Strategies. DOI 10.1016/j.ijrobp.2025.09.013↗
- Paper Radiotherapy in the management of PDAC, from past to present. DOI 10.1016/j.tranon.2025.102632↗
- Paper DDB2 expression lights the way for precision radiotherapy response in PDAC cells, with or without olaparib. DOI 10.1038/s41420-024-02188-9↗
- Aurélien Lambert · 4 shared papers, 2022–2026 · strength 0.93
- Paper Improving Radiation Therapy in Pancreatic Cancer Through Radiosensitization Strategies. DOI 10.1016/j.ijrobp.2025.09.013↗
- Paper Radiotherapy in the management of PDAC, from past to present. DOI 10.1016/j.tranon.2025.102632↗
- Paper DDB2 expression lights the way for precision radiotherapy response in PDAC cells, with or without olaparib. DOI 10.1038/s41420-024-02188-9↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.